Finalist recognition validates Prenosis’ pioneering work in AI-driven diagnostics for sepsis and its impact on critical care decision-making

Chicago, IL – October 8, 2025 — Prenosis has been named a Finalist in the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH. Prenosis was selected in the Rising Star – AI-Driven Diagnostics in Acute Care category.

This recognition highlights the company’s work advancing Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic tool for sepsis, which uses clinical data and biomarkers to generate predictive insights and support earlier, more confident decisions in acute care.

“The Digital Health Hub Awards shine a spotlight on solutions that are truly moving healthcare forward,” said Bobby Reddy, Jr., PhD, CEO and co-founder of Prenosis. “Being named a finalist is an honor that validates our mission to bring deeper biological insight to the healthcare community and to support clinicians with AI tools they can trust.”

From a pool of more than 1,800 submissions, only the most promising companies in each track and category advanced to the Finalist stage.

“Congratulations to all our 2025 finalists! Being recognized from among thousands of submissions is an incredible accomplishment. Your work is setting new standards in healthcare innovation, and we are proud to honor your progress. We look forward to celebrating the finalists and winners at HLTH,” said Mark H. Goldstein, chairman of the Digital Health Hub Foundation.

The 2025 winners will be announced live on October 20 at HLTH 2025, before an audience of global healthcare leaders, investors, and innovators.

About Prenosis, Inc.

Prenosis, Inc. is a biology-based technology company redefining the standard of care for critical conditions. We believe healthcare should not follow a one-size-fits-all model. Instead, our mission is to tailor healthcare to each patient’s biology through the creation and delivery of integrated diagnostics and therapeutics. We use deep data and AI to build tools that augment clinical diagnosis of critical conditions based on each patient’s unique biological profile. Unlike other AI-driven diagnostics, we go further by developing therapies that help providers deliver personalized care. Our Immunix™ platform powers the development of a variety of AI-based diagnostics, including Sepsis ImmunoScore™, the first FDA-authorized AI diagnostic tool for sepsis. At Prenosis, we see people differently. For more information, visit us at prenosis.com or find us on LinkedIn.

About Digital Health Hub Foundation

Founded in 2017 on the UCSF campus in San Francisco, the Digital Health Hub Foundation helps the world’s most innovative healthcare companies scale and grow. Its 30,000-member community includes early- to late-stage healthcare companies, providers, payors, mentors, investors, clinicians, and researchers. Each year, the Foundation’s awards program recognizes organizations making the most significant contributions to advancing healthcare through digital innovation.